MOLAND BIOVARME AS

4994 AKLAND

Finances

Share Ownership

Return on Equity

6,57 %

Current Ratio

3,93

Debt-to-Equity Ratio

0,24

Key figures (NOK)	2022	2021	2020	2019
Revenue	3 257 000	2 750 000	1 677 000	1 712 000
Net Income	376 000	354 000	−94 000	75 000
Total Assets	7 951 000	7 663 000	7 143 000	7 690 000
Total Equity	5 726 000	5 349 000	4 995 000	5 089 000

Income (NOK)	2022	2021	2020	2019
Revenue	3 257 000	2 750 000	1 677 000	1 712 000
Expenditure	2 734 000	2 245 000	1 731 000	1 549 000
Operating Profit	523 000	505 000	−55 000	165 000
Financial Income	0	0	0	1 000
Financial Costs	41 000	51 000	66 000	70 000
Financial Balance	−41 000	−51 000	−66 000	−69 000
Earnings Before Tax	482 000	454 000	−120 000	96 000
Tax	106 000	100 000	−26 000	21 000
Net Income	376 000	354 000	−94 000	75 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	4 626 000	5 212 000	5 428 000	5 722 000
Total Current Assets	3 325 000	2 451 000	1 714 000	1 967 000
Total Assets	7 951 000	7 663 000	7 143 000	7 690 000
Total Retained Equity	1 316 000	939 000	585 000	679 000
Total Equity	5 726 000	5 349 000	4 995 000	5 089 000
Total Long-Term Debt	1 380 000	1 710 000	1 896 000	2 208 000
Total Current Debt	846 000	604 000	251 000	393 000
Total Equity and Debt	7 951 000	7 663 000	7 143 000	7 690 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	3 257 000	2 750 000	1 677 000	1 712 000
Other Income	0	0	0	0
Revenue	3 257 000	2 750 000	1 677 000	1 712 000
Cost of Goods Sold	789 000	688 000	527 000	491 000
Salary Costs	11 000	22 000	22 000	22 000
Depreciation	586 000	558 000	537 000	545 000
Impairment	0	0	0	0
Expenditure	2 734 000	2 245 000	1 731 000	1 549 000
Operating Profit	523 000	505 000	−55 000	165 000
Financial Income	0	0	0	1 000
Financial Costs	41 000	51 000	66 000	70 000
Financial Balance	−41 000	−51 000	−66 000	−69 000
Dividends	0	0	0	0
Net Income	376 000	354 000	−94 000	75 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	1 788 000	2 019 000	2 250 000	2 481 000
Machinery and Plant Facilities	2 838 000	3 193 000	3 178 000	3 241 000
Fixtures	0	0	0	0
Total Tangible Assets	4 626 000	5 212 000	5 428 000	5 722 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	4 626 000	5 212 000	5 428 000	5 722 000
Stock	0	162 000	150 000	307 000
Total Investments	0	0	0	0
Cash, Bank	2 329 000	1 440 000	1 007 000	905 000
Total Current Assets	3 325 000	2 451 000	1 714 000	1 967 000
Total Assets	7 951 000	7 663 000	7 143 000	7 690 000
Total Equity	5 726 000	5 349 000	4 995 000	5 089 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	1 380 000	1 710 000	1 896 000	2 208 000
Creditors	445 000	548 000	231 000	212 000
Unpaid Taxes	133 000	0	2 000	51 000
Dividends	0	0	0	0
Other Current Debt	117 000	56 000	18 000	130 000
Total Current Debt	846 000	604 000	251 000	393 000
Total Equity and Debt	7 951 000	7 663 000	7 143 000	7 690 000

Financial indicators	2022	2021	2020	2019
Return on Equity	6,57 %	6,62 %	−1,88 %	1,47 %
Debt-to-Equity Ratio	0,24	0,32	0,38	0,43
Operating Profit Margin	16,06 %	18,36 %	−3,28 %	9,64 %
Current Ratio	3,93	4,06	6,83	5,01
Quick Ratio	3,93	5,55	16,97	22,87
Equity Ratio	0,72	0,7	0,7	0,66
Gross Profit Margin	75,78 %	74,98 %	68,57 %	71,32 %